Activity content starts in:
Industry Webcast
Rethinking Hyperkalemia Management in Patients on RAASi TherapyIndustry Webcast Sponsored by AstraZeneca; Not for CME/CE Credit
Discuss the burden of hyperkalemia in patients with CKD and heart failure, including recurrent hyperkalemia and risk of RAASi down-titration and discontinuation - Discuss guideline recommendations for treatment of hyperkalemia in the setting of CKD and heart failure - Review a potassium binder to treat hyperkalemia
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 10/16/2026
Expiration Date: 10/16/2026
Topics
Faculty
Faculty
Tim Burke
Learn MoreSupporters and Partners
Industry Sponsor
AstraZeneca
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.